nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2D6—Fingolimod—multiple sclerosis	0.0678	0.103	CbGbCtD
Diltiazem—ABCB1—Methylprednisolone—multiple sclerosis	0.0463	0.0704	CbGbCtD
Diltiazem—CYP3A4—Fingolimod—multiple sclerosis	0.0431	0.0654	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0359	0.0545	CbGbCtD
Diltiazem—CYP3A7—Dexamethasone—multiple sclerosis	0.0359	0.0545	CbGbCtD
Diltiazem—CYP2C19—Prednisone—multiple sclerosis	0.0348	0.0528	CbGbCtD
Diltiazem—ABCB1—Mitoxantrone—multiple sclerosis	0.0338	0.0513	CbGbCtD
Diltiazem—ABCB1—Betamethasone—multiple sclerosis	0.0301	0.0458	CbGbCtD
Diltiazem—ABCB1—Prednisolone—multiple sclerosis	0.0297	0.0451	CbGbCtD
Diltiazem—ABCB1—Prednisone—multiple sclerosis	0.0281	0.0426	CbGbCtD
Diltiazem—CYP3A4—Methylprednisolone—multiple sclerosis	0.0278	0.0422	CbGbCtD
Diltiazem—CYP3A5—Dexamethasone—multiple sclerosis	0.0269	0.0409	CbGbCtD
Diltiazem—CYP2C8—Dexamethasone—multiple sclerosis	0.0259	0.0393	CbGbCtD
Diltiazem—CYP2C19—Dexamethasone—multiple sclerosis	0.0217	0.033	CbGbCtD
Diltiazem—CYP3A4—Triamcinolone—multiple sclerosis	0.021	0.032	CbGbCtD
Diltiazem—CYP3A4—Mitoxantrone—multiple sclerosis	0.0203	0.0308	CbGbCtD
Diltiazem—CYP2C9—Dexamethasone—multiple sclerosis	0.0181	0.0274	CbGbCtD
Diltiazem—CYP3A4—Betamethasone—multiple sclerosis	0.0181	0.0274	CbGbCtD
Diltiazem—CYP3A4—Prednisolone—multiple sclerosis	0.0178	0.027	CbGbCtD
Diltiazem—ABCB1—Dexamethasone—multiple sclerosis	0.0175	0.0266	CbGbCtD
Diltiazem—CYP3A4—Prednisone—multiple sclerosis	0.0168	0.0255	CbGbCtD
Diltiazem—CYP2D6—Dexamethasone—multiple sclerosis	0.0165	0.0251	CbGbCtD
Diltiazem—ABCB1—Methotrexate—multiple sclerosis	0.0141	0.0214	CbGbCtD
Diltiazem—CYP3A4—Dexamethasone—multiple sclerosis	0.0105	0.0159	CbGbCtD
Diltiazem—Triflupromazine—BCHE—multiple sclerosis	0.000306	0.485	CrCbGaD
Diltiazem—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000273	0.00586	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00027	0.00578	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00027	0.00578	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000264	0.00567	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000264	0.00567	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000263	0.00563	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000262	0.00562	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000262	0.00562	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—FAS—multiple sclerosis	0.000237	0.00509	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000236	0.00506	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000218	0.00467	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—PRNP—multiple sclerosis	0.000217	0.00464	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000213	0.00457	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000213	0.00457	CbGpPWpGaD
Diltiazem—Discomfort—Triamcinolone—multiple sclerosis	0.000211	0.000717	CcSEcCtD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00021	0.00451	CbGpPWpGaD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00021	0.00451	CbGpPWpGaD
Diltiazem—Discomfort—Methylprednisolone—multiple sclerosis	0.00021	0.000716	CcSEcCtD
Diltiazem—Headache—Azathioprine—multiple sclerosis	0.00021	0.000715	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00021	0.000714	CcSEcCtD
Diltiazem—Dry mouth—Triamcinolone—multiple sclerosis	0.000209	0.00071	CcSEcCtD
Diltiazem—Renal failure—Methotrexate—multiple sclerosis	0.000208	0.000708	CcSEcCtD
Diltiazem—Angioedema—Dexamethasone—multiple sclerosis	0.000208	0.000707	CcSEcCtD
Diltiazem—Angioedema—Betamethasone—multiple sclerosis	0.000208	0.000707	CcSEcCtD
Diltiazem—Angiopathy—Prednisone—multiple sclerosis	0.000206	0.000702	CcSEcCtD
Diltiazem—Conjunctivitis—Methotrexate—multiple sclerosis	0.000206	0.0007	CcSEcCtD
Diltiazem—Malaise—Dexamethasone—multiple sclerosis	0.000205	0.000698	CcSEcCtD
Diltiazem—Malaise—Betamethasone—multiple sclerosis	0.000205	0.000698	CcSEcCtD
Diltiazem—Oedema—Triamcinolone—multiple sclerosis	0.000205	0.000696	CcSEcCtD
Diltiazem—Vertigo—Dexamethasone—multiple sclerosis	0.000204	0.000695	CcSEcCtD
Diltiazem—Vertigo—Betamethasone—multiple sclerosis	0.000204	0.000695	CcSEcCtD
Diltiazem—Syncope—Dexamethasone—multiple sclerosis	0.000204	0.000694	CcSEcCtD
Diltiazem—Syncope—Betamethasone—multiple sclerosis	0.000204	0.000694	CcSEcCtD
Diltiazem—Arrhythmia—Prednisone—multiple sclerosis	0.000203	0.000691	CcSEcCtD
Diltiazem—Infection—Triamcinolone—multiple sclerosis	0.000203	0.000691	CcSEcCtD
Diltiazem—Sweating—Methotrexate—multiple sclerosis	0.000203	0.000691	CcSEcCtD
Diltiazem—Infection—Methylprednisolone—multiple sclerosis	0.000203	0.00069	CcSEcCtD
Diltiazem—Shock—Triamcinolone—multiple sclerosis	0.000201	0.000685	CcSEcCtD
Diltiazem—Insomnia—Prednisolone—multiple sclerosis	0.000201	0.000684	CcSEcCtD
Diltiazem—Alopecia—Prednisone—multiple sclerosis	0.000201	0.000684	CcSEcCtD
Diltiazem—Shock—Methylprednisolone—multiple sclerosis	0.000201	0.000683	CcSEcCtD
Diltiazem—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.0002	0.000681	CcSEcCtD
Diltiazem—Loss of consciousness—Betamethasone—multiple sclerosis	0.0002	0.00068	CcSEcCtD
Diltiazem—Loss of consciousness—Dexamethasone—multiple sclerosis	0.0002	0.00068	CcSEcCtD
Diltiazem—Epistaxis—Methotrexate—multiple sclerosis	0.0002	0.00068	CcSEcCtD
Diltiazem—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.0002	0.00068	CcSEcCtD
Diltiazem—Paraesthesia—Prednisolone—multiple sclerosis	0.0002	0.00068	CcSEcCtD
Diltiazem—Tachycardia—Triamcinolone—multiple sclerosis	0.0002	0.000679	CcSEcCtD
Diltiazem—Nausea—Azathioprine—multiple sclerosis	0.000199	0.000678	CcSEcCtD
Diltiazem—Tachycardia—Methylprednisolone—multiple sclerosis	0.000199	0.000678	CcSEcCtD
Diltiazem—Erythema—Prednisone—multiple sclerosis	0.000198	0.000674	CcSEcCtD
Diltiazem—Malnutrition—Prednisone—multiple sclerosis	0.000198	0.000674	CcSEcCtD
Diltiazem—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000198	0.000673	CcSEcCtD
Diltiazem—Agranulocytosis—Methotrexate—multiple sclerosis	0.000198	0.000672	CcSEcCtD
Diltiazem—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000198	0.00423	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000198	0.00423	CbGpPWpGaD
Diltiazem—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000197	0.000671	CcSEcCtD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000195	0.00418	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000195	0.00418	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—IL1B—multiple sclerosis	0.000195	0.00417	CbGpPWpGaD
Diltiazem—Asthenia—Mitoxantrone—multiple sclerosis	0.000195	0.000662	CcSEcCtD
Diltiazem—Myalgia—Betamethasone—multiple sclerosis	0.000194	0.000659	CcSEcCtD
Diltiazem—Myalgia—Dexamethasone—multiple sclerosis	0.000194	0.000659	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000193	0.00413	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000193	0.00413	CbGpPWpGaD
Diltiazem—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000191	0.0041	CbGpPWpGaD
Diltiazem—Discomfort—Betamethasone—multiple sclerosis	0.000191	0.000651	CcSEcCtD
Diltiazem—Discomfort—Dexamethasone—multiple sclerosis	0.000191	0.000651	CcSEcCtD
Diltiazem—Hypotension—Methylprednisolone—multiple sclerosis	0.000191	0.000649	CcSEcCtD
Diltiazem—Pain—Prednisolone—multiple sclerosis	0.00019	0.000647	CcSEcCtD
Diltiazem—Hepatitis—Methotrexate—multiple sclerosis	0.00019	0.000647	CcSEcCtD
Diltiazem—Pharyngitis—Methotrexate—multiple sclerosis	0.000189	0.000642	CcSEcCtD
Diltiazem—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000188	0.000639	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000187	0.00402	CbGpPWpGaD
Diltiazem—Vision blurred—Prednisone—multiple sclerosis	0.000187	0.000635	CcSEcCtD
Diltiazem—Urethral disorder—Methotrexate—multiple sclerosis	0.000186	0.000634	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000186	0.000634	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000186	0.000633	CcSEcCtD
Diltiazem—Oedema—Betamethasone—multiple sclerosis	0.000186	0.000631	CcSEcCtD
Diltiazem—Oedema—Dexamethasone—multiple sclerosis	0.000186	0.000631	CcSEcCtD
Diltiazem—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000186	0.000631	CcSEcCtD
Diltiazem—Insomnia—Triamcinolone—multiple sclerosis	0.000185	0.000629	CcSEcCtD
Diltiazem—Insomnia—Methylprednisolone—multiple sclerosis	0.000185	0.000628	CcSEcCtD
Diltiazem—Infection—Betamethasone—multiple sclerosis	0.000184	0.000627	CcSEcCtD
Diltiazem—Infection—Dexamethasone—multiple sclerosis	0.000184	0.000627	CcSEcCtD
Diltiazem—Ill-defined disorder—Prednisone—multiple sclerosis	0.000184	0.000625	CcSEcCtD
Diltiazem—Paraesthesia—Triamcinolone—multiple sclerosis	0.000184	0.000625	CcSEcCtD
Diltiazem—Feeling abnormal—Prednisolone—multiple sclerosis	0.000183	0.000624	CcSEcCtD
Diltiazem—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000183	0.000624	CcSEcCtD
Diltiazem—Visual impairment—Methotrexate—multiple sclerosis	0.000183	0.000623	CcSEcCtD
Diltiazem—Shock—Dexamethasone—multiple sclerosis	0.000183	0.000621	CcSEcCtD
Diltiazem—Shock—Betamethasone—multiple sclerosis	0.000183	0.000621	CcSEcCtD
Diltiazem—Dyspnoea—Triamcinolone—multiple sclerosis	0.000182	0.00062	CcSEcCtD
Diltiazem—Nervous system disorder—Betamethasone—multiple sclerosis	0.000182	0.000619	CcSEcCtD
Diltiazem—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000182	0.000619	CcSEcCtD
Diltiazem—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000182	0.000618	CcSEcCtD
Diltiazem—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000182	0.000618	CcSEcCtD
Diltiazem—Tachycardia—Betamethasone—multiple sclerosis	0.000181	0.000616	CcSEcCtD
Diltiazem—Tachycardia—Dexamethasone—multiple sclerosis	0.000181	0.000616	CcSEcCtD
Diltiazem—Angioedema—Prednisone—multiple sclerosis	0.000181	0.000616	CcSEcCtD
Diltiazem—Dyspepsia—Triamcinolone—multiple sclerosis	0.00018	0.000613	CcSEcCtD
Diltiazem—Erythema multiforme—Methotrexate—multiple sclerosis	0.00018	0.000612	CcSEcCtD
Diltiazem—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00018	0.000611	CcSEcCtD
Diltiazem—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000179	0.00061	CcSEcCtD
Diltiazem—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000179	0.00061	CcSEcCtD
Diltiazem—Malaise—Prednisone—multiple sclerosis	0.000179	0.000608	CcSEcCtD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000178	0.00382	CbGpPWpGaD
Diltiazem—Vertigo—Prednisone—multiple sclerosis	0.000178	0.000605	CcSEcCtD
Diltiazem—Eye disorder—Methotrexate—multiple sclerosis	0.000178	0.000605	CcSEcCtD
Diltiazem—Syncope—Prednisone—multiple sclerosis	0.000178	0.000604	CcSEcCtD
Diltiazem—Tinnitus—Methotrexate—multiple sclerosis	0.000177	0.000603	CcSEcCtD
Diltiazem—Anorexia—Dexamethasone—multiple sclerosis	0.000177	0.000602	CcSEcCtD
Diltiazem—Anorexia—Betamethasone—multiple sclerosis	0.000177	0.000602	CcSEcCtD
Diltiazem—Urticaria—Prednisolone—multiple sclerosis	0.000177	0.000601	CcSEcCtD
Diltiazem—Cardiac disorder—Methotrexate—multiple sclerosis	0.000177	0.0006	CcSEcCtD
Diltiazem—Fatigue—Triamcinolone—multiple sclerosis	0.000176	0.0006	CcSEcCtD
Diltiazem—Fatigue—Methylprednisolone—multiple sclerosis	0.000176	0.000599	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000175	0.00375	CbGpPWpGaD
Diltiazem—Pain—Triamcinolone—multiple sclerosis	0.000175	0.000595	CcSEcCtD
Diltiazem—Loss of consciousness—Prednisone—multiple sclerosis	0.000174	0.000592	CcSEcCtD
Diltiazem—Hypotension—Betamethasone—multiple sclerosis	0.000174	0.00059	CcSEcCtD
Diltiazem—Hypotension—Dexamethasone—multiple sclerosis	0.000174	0.00059	CcSEcCtD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000173	0.00371	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000173	0.00371	CbGpPWpGaD
Diltiazem—Angiopathy—Methotrexate—multiple sclerosis	0.000173	0.000587	CcSEcCtD
Diltiazem—Vomiting—Mitoxantrone—multiple sclerosis	0.000172	0.000587	CcSEcCtD
Diltiazem—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000171	0.000583	CcSEcCtD
Diltiazem—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000171	0.00367	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000171	0.00367	CbGpPWpGaD
Diltiazem—Rash—Mitoxantrone—multiple sclerosis	0.000171	0.000582	CcSEcCtD
Diltiazem—Dermatitis—Mitoxantrone—multiple sclerosis	0.000171	0.000581	CcSEcCtD
Diltiazem—Headache—Mitoxantrone—multiple sclerosis	0.00017	0.000578	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000169	0.000575	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000169	0.000575	CcSEcCtD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000169	0.00362	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000169	0.00362	CbGpPWpGaD
Diltiazem—Arthralgia—Prednisone—multiple sclerosis	0.000169	0.000574	CcSEcCtD
Diltiazem—Myalgia—Prednisone—multiple sclerosis	0.000169	0.000574	CcSEcCtD
Diltiazem—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000169	0.000574	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—PTPRC—multiple sclerosis	0.000168	0.00361	CbGpPWpGaD
Diltiazem—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000168	0.000572	CcSEcCtD
Diltiazem—Alopecia—Methotrexate—multiple sclerosis	0.000168	0.000572	CcSEcCtD
Diltiazem—Insomnia—Dexamethasone—multiple sclerosis	0.000168	0.000571	CcSEcCtD
Diltiazem—Insomnia—Betamethasone—multiple sclerosis	0.000168	0.000571	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000167	0.00358	CbGpPWpGaD
Diltiazem—Paraesthesia—Dexamethasone—multiple sclerosis	0.000167	0.000567	CcSEcCtD
Diltiazem—Paraesthesia—Betamethasone—multiple sclerosis	0.000167	0.000567	CcSEcCtD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000167	0.00357	CbGpPWpGaD
Diltiazem—Discomfort—Prednisone—multiple sclerosis	0.000167	0.000567	CcSEcCtD
Diltiazem—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000166	0.00356	CbGpPWpGaD
Diltiazem—Malnutrition—Methotrexate—multiple sclerosis	0.000166	0.000563	CcSEcCtD
Diltiazem—Erythema—Methotrexate—multiple sclerosis	0.000166	0.000563	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000165	0.00354	CbGpPWpGaD
Diltiazem—Hypersensitivity—Prednisolone—multiple sclerosis	0.000164	0.000558	CcSEcCtD
Diltiazem—Dyspepsia—Betamethasone—multiple sclerosis	0.000163	0.000556	CcSEcCtD
Diltiazem—Dyspepsia—Dexamethasone—multiple sclerosis	0.000163	0.000556	CcSEcCtD
Diltiazem—Urticaria—Triamcinolone—multiple sclerosis	0.000163	0.000553	CcSEcCtD
Diltiazem—Urticaria—Methylprednisolone—multiple sclerosis	0.000162	0.000552	CcSEcCtD
Diltiazem—Dysgeusia—Methotrexate—multiple sclerosis	0.000162	0.000551	CcSEcCtD
Diltiazem—Body temperature increased—Triamcinolone—multiple sclerosis	0.000162	0.00055	CcSEcCtD
Diltiazem—Oedema—Prednisone—multiple sclerosis	0.000162	0.00055	CcSEcCtD
Diltiazem—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000161	0.000549	CcSEcCtD
Diltiazem—Decreased appetite—Dexamethasone—multiple sclerosis	0.000161	0.000549	CcSEcCtD
Diltiazem—Decreased appetite—Betamethasone—multiple sclerosis	0.000161	0.000549	CcSEcCtD
Diltiazem—Nausea—Mitoxantrone—multiple sclerosis	0.000161	0.000548	CcSEcCtD
Diltiazem—Infection—Prednisone—multiple sclerosis	0.000161	0.000546	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00016	0.000545	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00016	0.000545	CcSEcCtD
Diltiazem—Fatigue—Dexamethasone—multiple sclerosis	0.00016	0.000544	CcSEcCtD
Diltiazem—Fatigue—Betamethasone—multiple sclerosis	0.00016	0.000544	CcSEcCtD
Diltiazem—Shock—Prednisone—multiple sclerosis	0.000159	0.000541	CcSEcCtD
Diltiazem—Pain—Betamethasone—multiple sclerosis	0.000159	0.00054	CcSEcCtD
Diltiazem—Pain—Dexamethasone—multiple sclerosis	0.000159	0.00054	CcSEcCtD
Diltiazem—Nervous system disorder—Prednisone—multiple sclerosis	0.000159	0.000539	CcSEcCtD
Diltiazem—Tachycardia—Prednisone—multiple sclerosis	0.000158	0.000537	CcSEcCtD
Diltiazem—Hyperhidrosis—Prednisone—multiple sclerosis	0.000156	0.000532	CcSEcCtD
Diltiazem—Vision blurred—Methotrexate—multiple sclerosis	0.000156	0.000531	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—PRNP—multiple sclerosis	0.000155	0.00331	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000154	0.00331	CbGpPWpGaD
Diltiazem—Anorexia—Prednisone—multiple sclerosis	0.000154	0.000524	CcSEcCtD
Diltiazem—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000154	0.000523	CcSEcCtD
Diltiazem—Feeling abnormal—Betamethasone—multiple sclerosis	0.000153	0.00052	CcSEcCtD
Diltiazem—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000153	0.00052	CcSEcCtD
Diltiazem—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000153	0.00328	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000153	0.00327	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000153	0.00327	CbGpPWpGaD
Diltiazem—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000151	0.000513	CcSEcCtD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000151	0.00323	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000151	0.00323	CbGpPWpGaD
Diltiazem—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00015	0.000512	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.00015	0.00322	CbGpPWpGaD
Diltiazem—Malaise—Methotrexate—multiple sclerosis	0.000149	0.000508	CcSEcCtD
Diltiazem—Vertigo—Methotrexate—multiple sclerosis	0.000149	0.000506	CcSEcCtD
Diltiazem—CACNA1S—Alzheimers Disease—MAPK1—multiple sclerosis	0.000148	0.00318	CbGpPWpGaD
Diltiazem—Leukopenia—Methotrexate—multiple sclerosis	0.000148	0.000504	CcSEcCtD
Diltiazem—Urticaria—Dexamethasone—multiple sclerosis	0.000148	0.000502	CcSEcCtD
Diltiazem—Urticaria—Betamethasone—multiple sclerosis	0.000148	0.000502	CcSEcCtD
Diltiazem—Chlorpromazine—BCHE—multiple sclerosis	0.000147	0.234	CrCbGaD
Diltiazem—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000147	0.000501	CcSEcCtD
Diltiazem—Dizziness—Prednisolone—multiple sclerosis	0.000147	0.0005	CcSEcCtD
Diltiazem—Asthenia—Triamcinolone—multiple sclerosis	0.000147	0.000499	CcSEcCtD
Diltiazem—Body temperature increased—Dexamethasone—multiple sclerosis	0.000147	0.000499	CcSEcCtD
Diltiazem—Abdominal pain—Betamethasone—multiple sclerosis	0.000147	0.000499	CcSEcCtD
Diltiazem—Body temperature increased—Betamethasone—multiple sclerosis	0.000147	0.000499	CcSEcCtD
Diltiazem—Abdominal pain—Dexamethasone—multiple sclerosis	0.000147	0.000499	CcSEcCtD
Diltiazem—Asthenia—Methylprednisolone—multiple sclerosis	0.000146	0.000498	CcSEcCtD
Diltiazem—Insomnia—Prednisone—multiple sclerosis	0.000146	0.000497	CcSEcCtD
Diltiazem—Paraesthesia—Prednisone—multiple sclerosis	0.000145	0.000494	CcSEcCtD
Diltiazem—Pruritus—Triamcinolone—multiple sclerosis	0.000145	0.000492	CcSEcCtD
Diltiazem—Cough—Methotrexate—multiple sclerosis	0.000144	0.000491	CcSEcCtD
Diltiazem—Pruritus—Methylprednisolone—multiple sclerosis	0.000144	0.000491	CcSEcCtD
Diltiazem—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000143	0.00306	CbGpPWpGaD
Diltiazem—Dyspepsia—Prednisone—multiple sclerosis	0.000142	0.000484	CcSEcCtD
Diltiazem—CACNA1S—Alzheimers Disease—TNF—multiple sclerosis	0.000141	0.00303	CbGpPWpGaD
Diltiazem—Chest pain—Methotrexate—multiple sclerosis	0.000141	0.000479	CcSEcCtD
Diltiazem—Arthralgia—Methotrexate—multiple sclerosis	0.000141	0.000479	CcSEcCtD
Diltiazem—Myalgia—Methotrexate—multiple sclerosis	0.000141	0.000479	CcSEcCtD
Diltiazem—Decreased appetite—Prednisone—multiple sclerosis	0.000141	0.000478	CcSEcCtD
Diltiazem—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.00014	0.00301	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.00014	0.00301	CbGpPWpGaD
Diltiazem—Rash—Prednisolone—multiple sclerosis	0.00014	0.000477	CcSEcCtD
Diltiazem—Dermatitis—Prednisolone—multiple sclerosis	0.00014	0.000477	CcSEcCtD
Diltiazem—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00014	0.000475	CcSEcCtD
Diltiazem—Fatigue—Prednisone—multiple sclerosis	0.000139	0.000474	CcSEcCtD
Diltiazem—Headache—Prednisolone—multiple sclerosis	0.000139	0.000474	CcSEcCtD
Diltiazem—Discomfort—Methotrexate—multiple sclerosis	0.000139	0.000474	CcSEcCtD
Diltiazem—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000139	0.00298	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000139	0.00298	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	0.000139	0.00298	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000139	0.00297	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000139	0.00297	CbGpPWpGaD
Diltiazem—Constipation—Prednisone—multiple sclerosis	0.000138	0.00047	CcSEcCtD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000137	0.00294	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000137	0.00294	CbGpPWpGaD
Diltiazem—Dizziness—Triamcinolone—multiple sclerosis	0.000135	0.00046	CcSEcCtD
Diltiazem—Dizziness—Methylprednisolone—multiple sclerosis	0.000135	0.000459	CcSEcCtD
Diltiazem—Infection—Methotrexate—multiple sclerosis	0.000134	0.000457	CcSEcCtD
Diltiazem—Feeling abnormal—Prednisone—multiple sclerosis	0.000133	0.000453	CcSEcCtD
Diltiazem—Asthenia—Betamethasone—multiple sclerosis	0.000133	0.000453	CcSEcCtD
Diltiazem—Asthenia—Dexamethasone—multiple sclerosis	0.000133	0.000453	CcSEcCtD
Diltiazem—Nervous system disorder—Methotrexate—multiple sclerosis	0.000133	0.000451	CcSEcCtD
Diltiazem—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000132	0.00045	CcSEcCtD
Diltiazem—Nausea—Prednisolone—multiple sclerosis	0.000132	0.00045	CcSEcCtD
Diltiazem—Pruritus—Betamethasone—multiple sclerosis	0.000131	0.000447	CcSEcCtD
Diltiazem—Pruritus—Dexamethasone—multiple sclerosis	0.000131	0.000447	CcSEcCtD
Diltiazem—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000131	0.000444	CcSEcCtD
Diltiazem—Vomiting—Triamcinolone—multiple sclerosis	0.00013	0.000443	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.00013	0.00279	CbGpPWpGaD
Diltiazem—Vomiting—Methylprednisolone—multiple sclerosis	0.00013	0.000442	CcSEcCtD
Diltiazem—Rash—Triamcinolone—multiple sclerosis	0.000129	0.000439	CcSEcCtD
Diltiazem—Dermatitis—Triamcinolone—multiple sclerosis	0.000129	0.000438	CcSEcCtD
Diltiazem—Anorexia—Methotrexate—multiple sclerosis	0.000129	0.000438	CcSEcCtD
Diltiazem—Rash—Methylprednisolone—multiple sclerosis	0.000129	0.000438	CcSEcCtD
Diltiazem—Dermatitis—Methylprednisolone—multiple sclerosis	0.000129	0.000437	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000128	0.00275	CbGpPWpGaD
Diltiazem—Urticaria—Prednisone—multiple sclerosis	0.000128	0.000437	CcSEcCtD
Diltiazem—Headache—Triamcinolone—multiple sclerosis	0.000128	0.000436	CcSEcCtD
Diltiazem—Headache—Methylprednisolone—multiple sclerosis	0.000128	0.000435	CcSEcCtD
Diltiazem—Abdominal pain—Prednisone—multiple sclerosis	0.000128	0.000435	CcSEcCtD
Diltiazem—Body temperature increased—Prednisone—multiple sclerosis	0.000128	0.000435	CcSEcCtD
Diltiazem—Diarrhoea—Betamethasone—multiple sclerosis	0.000127	0.000432	CcSEcCtD
Diltiazem—Diarrhoea—Dexamethasone—multiple sclerosis	0.000127	0.000432	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000126	0.00271	CbGpPWpGaD
Diltiazem—Hypotension—Methotrexate—multiple sclerosis	0.000126	0.000429	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000123	0.000419	CcSEcCtD
Diltiazem—Dizziness—Betamethasone—multiple sclerosis	0.000123	0.000418	CcSEcCtD
Diltiazem—Dizziness—Dexamethasone—multiple sclerosis	0.000123	0.000418	CcSEcCtD
Diltiazem—Insomnia—Methotrexate—multiple sclerosis	0.000122	0.000416	CcSEcCtD
Diltiazem—Nausea—Triamcinolone—multiple sclerosis	0.000122	0.000413	CcSEcCtD
Diltiazem—Paraesthesia—Methotrexate—multiple sclerosis	0.000121	0.000413	CcSEcCtD
Diltiazem—Nausea—Methylprednisolone—multiple sclerosis	0.000121	0.000412	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000121	0.00259	CbGpPWpGaD
Diltiazem—Dyspnoea—Methotrexate—multiple sclerosis	0.00012	0.00041	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—PTPRC—multiple sclerosis	0.00012	0.00258	CbGpPWpGaD
Diltiazem—Somnolence—Methotrexate—multiple sclerosis	0.00012	0.000409	CcSEcCtD
Diltiazem—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	0.00012	0.00257	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.00012	0.00257	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000119	0.00256	CbGpPWpGaD
Diltiazem—Hypersensitivity—Prednisone—multiple sclerosis	0.000119	0.000405	CcSEcCtD
Diltiazem—Dyspepsia—Methotrexate—multiple sclerosis	0.000119	0.000405	CcSEcCtD
Diltiazem—Vomiting—Dexamethasone—multiple sclerosis	0.000118	0.000402	CcSEcCtD
Diltiazem—Vomiting—Betamethasone—multiple sclerosis	0.000118	0.000402	CcSEcCtD
Diltiazem—Decreased appetite—Methotrexate—multiple sclerosis	0.000117	0.0004	CcSEcCtD
Diltiazem—Rash—Betamethasone—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Diltiazem—Rash—Dexamethasone—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Diltiazem—Dermatitis—Dexamethasone—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Diltiazem—Dermatitis—Betamethasone—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000117	0.000397	CcSEcCtD
Diltiazem—Fatigue—Methotrexate—multiple sclerosis	0.000117	0.000396	CcSEcCtD
Diltiazem—Headache—Dexamethasone—multiple sclerosis	0.000116	0.000396	CcSEcCtD
Diltiazem—Headache—Betamethasone—multiple sclerosis	0.000116	0.000396	CcSEcCtD
Diltiazem—Acepromazine—ALB—multiple sclerosis	0.000116	0.184	CrCbGaD
Diltiazem—Asthenia—Prednisone—multiple sclerosis	0.000116	0.000395	CcSEcCtD
Diltiazem—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000116	0.00248	CbGpPWpGaD
Diltiazem—Pain—Methotrexate—multiple sclerosis	0.000116	0.000393	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000115	0.00247	CbGpPWpGaD
Diltiazem—Pruritus—Prednisone—multiple sclerosis	0.000114	0.000389	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000114	0.00244	CbGpPWpGaD
Diltiazem—Feeling abnormal—Methotrexate—multiple sclerosis	0.000111	0.000379	CcSEcCtD
Diltiazem—Diarrhoea—Prednisone—multiple sclerosis	0.000111	0.000376	CcSEcCtD
Diltiazem—Nausea—Dexamethasone—multiple sclerosis	0.00011	0.000375	CcSEcCtD
Diltiazem—Nausea—Betamethasone—multiple sclerosis	0.00011	0.000375	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	0.00011	0.00236	CbGpPWpGaD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00011	0.00236	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—SRM—multiple sclerosis	0.000108	0.00232	CbGpPWpGaD
Diltiazem—Urticaria—Methotrexate—multiple sclerosis	0.000107	0.000365	CcSEcCtD
Diltiazem—Dizziness—Prednisone—multiple sclerosis	0.000107	0.000364	CcSEcCtD
Diltiazem—Abdominal pain—Methotrexate—multiple sclerosis	0.000107	0.000363	CcSEcCtD
Diltiazem—Body temperature increased—Methotrexate—multiple sclerosis	0.000107	0.000363	CcSEcCtD
Diltiazem—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000106	0.00227	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000104	0.00223	CbGpPWpGaD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000103	0.00221	CbGpPWpGaD
Diltiazem—Vomiting—Prednisone—multiple sclerosis	0.000103	0.00035	CcSEcCtD
Diltiazem—Rash—Prednisone—multiple sclerosis	0.000102	0.000347	CcSEcCtD
Diltiazem—Dermatitis—Prednisone—multiple sclerosis	0.000102	0.000346	CcSEcCtD
Diltiazem—Headache—Prednisone—multiple sclerosis	0.000101	0.000345	CcSEcCtD
Diltiazem—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	0.000101	0.00216	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.0001	0.00215	CbGpPWpGaD
Diltiazem—Hypersensitivity—Methotrexate—multiple sclerosis	9.96e-05	0.000339	CcSEcCtD
Diltiazem—Asthenia—Methotrexate—multiple sclerosis	9.7e-05	0.00033	CcSEcCtD
Diltiazem—Nausea—Prednisone—multiple sclerosis	9.6e-05	0.000327	CcSEcCtD
Diltiazem—Pruritus—Methotrexate—multiple sclerosis	9.56e-05	0.000325	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	9.36e-05	0.00201	CbGpPWpGaD
Diltiazem—Diarrhoea—Methotrexate—multiple sclerosis	9.25e-05	0.000314	CcSEcCtD
Diltiazem—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.19e-05	0.00197	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.19e-05	0.00197	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	9.17e-05	0.00196	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.06e-05	0.00194	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.06e-05	0.00194	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.02e-05	0.00193	CbGpPWpGaD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.94e-05	0.00192	CbGpPWpGaD
Diltiazem—Dizziness—Methotrexate—multiple sclerosis	8.94e-05	0.000304	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—IL10—multiple sclerosis	8.84e-05	0.0019	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	8.84e-05	0.0019	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL4—multiple sclerosis	8.6e-05	0.00184	CbGpPWpGaD
Diltiazem—Vomiting—Methotrexate—multiple sclerosis	8.59e-05	0.000292	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	8.57e-05	0.00184	CbGpPWpGaD
Diltiazem—Rash—Methotrexate—multiple sclerosis	8.52e-05	0.00029	CcSEcCtD
Diltiazem—Dermatitis—Methotrexate—multiple sclerosis	8.51e-05	0.00029	CcSEcCtD
Diltiazem—Headache—Methotrexate—multiple sclerosis	8.47e-05	0.000288	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	8.41e-05	0.0018	CbGpPWpGaD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.37e-05	0.00179	CbGpPWpGaD
Diltiazem—Nausea—Methotrexate—multiple sclerosis	8.03e-05	0.000273	CcSEcCtD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.98e-05	0.00171	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—FAS—multiple sclerosis	7.93e-05	0.0017	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	7.88e-05	0.00169	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	7.79e-05	0.00167	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	7.63e-05	0.00164	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	7.63e-05	0.00164	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—TYK2—multiple sclerosis	7.53e-05	0.00161	CbGpPWpGaD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.34e-05	0.00157	CbGpPWpGaD
Diltiazem—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.28e-05	0.00156	CbGpPWpGaD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.25e-05	0.00155	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.12e-05	0.00153	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GPC5—multiple sclerosis	6.98e-05	0.0015	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—SRM—multiple sclerosis	6.63e-05	0.00142	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.58e-05	0.00141	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.57e-05	0.00141	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.57e-05	0.00141	CbGpPWpGaD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.47e-05	0.00139	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—POMC—multiple sclerosis	6.15e-05	0.00132	CbGpPWpGaD
Diltiazem—Chlorpromazine—ALB—multiple sclerosis	6.05e-05	0.0961	CrCbGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.95e-05	0.00128	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MMP9—multiple sclerosis	5.93e-05	0.00127	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.9e-05	0.00126	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.87e-05	0.00126	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.87e-05	0.00126	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.86e-05	0.00125	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—RRM1—multiple sclerosis	5.78e-05	0.00124	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.69e-05	0.00122	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TYK2—multiple sclerosis	5.38e-05	0.00115	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—TYK2—multiple sclerosis	5.37e-05	0.00115	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.35e-05	0.00115	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.35e-05	0.00115	CbGpPWpGaD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.29e-05	0.00113	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.2e-05	0.00111	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.8e-05	0.00103	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MAPK1—multiple sclerosis	4.8e-05	0.00103	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—SRM—multiple sclerosis	4.8e-05	0.00103	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4.67e-05	0.001	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4.67e-05	0.001	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.64e-05	0.000994	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.62e-05	0.00099	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.57e-05	0.00098	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.44e-05	0.000953	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.44e-05	0.000951	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.28e-05	0.000916	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MMP9—multiple sclerosis	4.23e-05	0.000908	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MMP9—multiple sclerosis	4.23e-05	0.000907	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SRM—multiple sclerosis	4.15e-05	0.00089	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.91e-05	0.000838	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.89e-05	0.000834	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.85e-05	0.000825	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	3.84e-05	0.000822	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	3.76e-05	0.000807	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SRM—multiple sclerosis	3.71e-05	0.000795	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—IL6—multiple sclerosis	3.69e-05	0.00079	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SRM—multiple sclerosis	3.62e-05	0.000776	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.6e-05	0.000772	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.000759	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.51e-05	0.000752	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	3.49e-05	0.000748	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.44e-05	0.000736	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	3.42e-05	0.000733	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	3.42e-05	0.000733	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SRM—multiple sclerosis	3.41e-05	0.000731	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SRM—multiple sclerosis	3.38e-05	0.000725	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.38e-05	0.000724	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.38e-05	0.000724	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.37e-05	0.000721	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—BCHE—multiple sclerosis	3.32e-05	0.000712	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TNF—multiple sclerosis	3.26e-05	0.000698	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.16e-05	0.000677	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.13e-05	0.000671	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.1e-05	0.000665	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.09e-05	0.000662	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	3.02e-05	0.000647	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.93e-05	0.000627	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.93e-05	0.000627	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.86e-05	0.000613	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	2.69e-05	0.000576	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.68e-05	0.000574	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—IL6—multiple sclerosis	2.63e-05	0.000564	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—IL6—multiple sclerosis	2.63e-05	0.000563	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.61e-05	0.00056	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.61e-05	0.00056	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.56e-05	0.000549	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.55e-05	0.000547	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.55e-05	0.000546	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.55e-05	0.000546	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	2.49e-05	0.000534	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	2.44e-05	0.000523	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.4e-05	0.000515	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.4e-05	0.000515	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.39e-05	0.000512	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.38e-05	0.00051	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.38e-05	0.00051	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GPC5—multiple sclerosis	2.33e-05	0.0005	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.33e-05	0.000499	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TNF—multiple sclerosis	2.32e-05	0.000498	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SRM—multiple sclerosis	2.23e-05	0.000478	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.22e-05	0.000475	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.2e-05	0.000471	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.18e-05	0.000467	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.07e-05	0.000443	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.03e-05	0.000436	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—APOE—multiple sclerosis	2e-05	0.000428	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000424	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—RRM1—multiple sclerosis	1.93e-05	0.000414	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—IL6—multiple sclerosis	1.88e-05	0.000402	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.82e-05	0.00039	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.81e-05	0.000387	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.78e-05	0.000382	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.78e-05	0.000381	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.74e-05	0.000374	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.72e-05	0.000369	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—POMC—multiple sclerosis	1.72e-05	0.000368	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.66e-05	0.000356	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.57e-05	0.000337	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.57e-05	0.000337	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—ALB—multiple sclerosis	1.57e-05	0.000336	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.54e-05	0.000329	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.48e-05	0.000317	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000315	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.44e-05	0.000308	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.4e-05	0.0003	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.35e-05	0.000289	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.32e-05	0.000283	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.27e-05	0.000273	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000262	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.2e-05	0.000258	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000258	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.19e-05	0.000255	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000244	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.12e-05	0.000239	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—BCHE—multiple sclerosis	1.11e-05	0.000238	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.1e-05	0.000235	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000225	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.05e-05	0.000224	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.04e-05	0.000222	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ALB—multiple sclerosis	9.59e-06	0.000205	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—APOE—multiple sclerosis	8.85e-06	0.00019	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—APOE—multiple sclerosis	7.66e-06	0.000164	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—POMC—multiple sclerosis	7.6e-06	0.000163	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ALB—multiple sclerosis	6.93e-06	0.000149	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—APOE—multiple sclerosis	6.84e-06	0.000147	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.84e-06	0.000147	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—APOE—multiple sclerosis	6.68e-06	0.000143	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—POMC—multiple sclerosis	6.58e-06	0.000141	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—APOE—multiple sclerosis	6.29e-06	0.000135	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—APOE—multiple sclerosis	6.24e-06	0.000134	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ALB—multiple sclerosis	6e-06	0.000129	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—POMC—multiple sclerosis	5.88e-06	0.000126	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—POMC—multiple sclerosis	5.74e-06	0.000123	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—POMC—multiple sclerosis	5.4e-06	0.000116	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—POMC—multiple sclerosis	5.36e-06	0.000115	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ALB—multiple sclerosis	5.36e-06	0.000115	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ALB—multiple sclerosis	5.23e-06	0.000112	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ALB—multiple sclerosis	4.93e-06	0.000106	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ALB—multiple sclerosis	4.88e-06	0.000105	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—APOE—multiple sclerosis	4.11e-06	8.82e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—POMC—multiple sclerosis	3.53e-06	7.57e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ALB—multiple sclerosis	3.22e-06	6.9e-05	CbGpPWpGaD
